InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
17,060.40
(
0.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.29
(
0.08%
)
Bitcoin
64,314.63
(
0.05%
)
Post# of 474
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Triple9

Send PM Follow Ignore
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Triple9

Re: None

Wednesday, 09/27/2017 12:00:37 PM

Wednesday, September 27, 2017 12:00:37 PM

Post# of 474
Three current FDA Phase 1/2 trials, for $SGMO:

MPS I (Scheie, Hurler-Scheie and Hurler syndromes)
MPS II (Hunter syndrome)
Hemophilia B

https://www.biopharmcatalyst.com/company/SGMO

Know What You Own. My posts should not be construed as investment advice.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SGMO News
More SGMO News
InvestorsHub NewsWire

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Start posting your company's news
Only $200 per official company press release!